Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endothelin converting enzyme like 1 pseudogene 2 (ECEL1P2) is a human pseudogene and does not encode a functional protein product. It is an unprocessed pseudogene related to the ECEL1 gene, which encodes an endopeptidase in the M13 family, but ECEL1P2 itself is not known to have any biological or clinical function, nor is it considered a therapeutic target. ECEL1P2 is also known as ECEL2, but this designation may lead to confusion with active family members. As a pseudogene, ECEL1P2 does not participate in signal transduction, enzymatic activity, or other canonical biological roles and is not linked to disease mechanisms, biomarkers, or druggability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endothelin converting enzyme like 1 pseudogene 2 (ECEL1P2).